ESR1 and breast carcinoma: On the other hand, studies have shown that six breast cancer cell lines (ER+:[UCD4, UCD12, and UCD65] and ER−:[UCD46, UCD115, and UCD178]) have been created from PDXs to increase the overall ER+ number of cell lines within the archive to manipulate for breast cancer research [144].